Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented Ischemic disease

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2273-2279

  Moon, Jae Hoon ^a,b   Chae, Min Kyung ^b   Kim, Kwang Joon ^c   Kim, Hyun Min ^b   Cha, Bong Soo ^b   Lee, Hyun Chul ^b   Kim, Young Jin ^b   Lee, Byung Wan ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Atherogenesis; Endothelial progenitor cell; Glycated albumin; Plaque formation; Type 2 diabetes mellitus

Indexed keywords

GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIGENS, CD; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; FEMALE; HUMANS; ISCHEMIA; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SERUM ALBUMIN; STEM CELLS;

EID: 84865515973     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1499     Document Type: Article

References (40)

1. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia-and cytokine-induced mobilization of bone marrowderived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
2. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
3. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
4. George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003; 23: e57-e60.
5. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
6. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
7. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226.
8. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-2067.
9. Muller-Ehmsen J, Braun D, Schneider T, Pfister R, Worm N, Wielckens K, et al. Decreased number of circulating progenitor cells in obesity: Beneficial effects of weight reduction. Eur Heart J 2008; 29: 1560-1568.
10. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
11. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, et al. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J 2006; 152: 190-195.
12. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
13. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis: Results from a large population-based study. PLoS One 2007; 2: e975.
14. Sandri M, Beck EB, Adams V, Gielen S, Lenk K, Hollriegel R, et al. Maximal exercise, limb ischemia, and endothelial progenitor cells. Eur J Cardiovasc Prev Rehabil 2011; 18: 55-64.
15. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004; 24: 684-690.
16. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199-206.
17. Kim SK, Park SW, Kim SH, Cha BS, Lee HC, Cho YW. Visceral fat amount is associated with carotid atherosclerosis even in type 2 diabetic men with a normal waist circumference. Int J Obes (Lond) 2009; 33: 131-135.
18. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
19. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007; 194: 46-54.
20. Cubbon RM, Kahn MB, Wheatcroft SB. Effects of insulin resistance on endothelial progenitor cells and vascular repair. Clin Sci (Lond) 2009; 117: 173-190.
21. Jeong IK, King GL. New perspectives on diabetic vascular complications: The loss of endogenous protective factors induced by hyperglycemia. Diabetes Metab J 2011; 35: 8-11.
22. Kim HM, Kim KJ, Moon JH, Lee HJ, Chae MK, Chang HJ, et al. Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients. Acta Diabetol 2011 December 13 [Epub ahead of print].
23. Stauffer BL, Maceneaney OJ, Kushner EJ, Cech JN, Greiner JJ, Westby CM, et al. Gender and endothelial progenitor cell number in middleaged adults. Artery Res 2008; 2: 156-160.
24. Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: The role of female estrogens. Arterioscler Thromb Vasc Biol 2008; 28: 997-1004.
25. Fadini GP, Boscaro E, Albiero M, Menegazzo L, Frison V, de Kreutzenberg S, et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha. Diabetes Care 2010; 33: 1607-1609.
26. Lavi R, Zhu XY, Chade AR, Lin J, Lerman A, Lerman LO. Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2010; 30: 976-983.
27. Schmidt-Lucke C, Fichtlscherer S, Rossig L, Kamper U, Dimmeler S. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 2010; 211: 249-254.
28. Lee EY, Lee BW, Kim D, Lee YH, Kim KJ, Kang ES, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 2011; 48: 167-172.
29. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008; 55: 503-507.
30. Rodino-Janeiro BK, Gonzalez-Peteiro M, Ucieda-Somoza R, Gonzalez-Juanatey JR, Alvarez E. Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: Molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev 2010; 26: 550-558.
31. Kim J, Kim KS, Shinn JW, Oh YS, Kim HT, Jo I, et al. The effect of antioxidants on glycated albumin-induced cytotoxicity in bovine retinal pericytes. Biochem Biophys Res Commun 2002; 292: 1010-1016.
32. Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J Lab Clin Med 2003; 141: 242-249.
33. Lee BW, Ihm J, Kang JG, Choi MG, Yoo HJ, Ihm SH. Amadoriglycated albumin-induced vascular smooth muscle cell proliferation and expression of inhibitor of apoptosis protein-1 and nerve growth factor-gamma. Biofactors 2007; 31: 145-153.
34. Bai X, Wang X, Xu Q. Endothelial damage and stem cell repair in atherosclerosis. Vascul Pharmacol 2010; 52: 224-229.
35. + progenitor cells in patients with stable angina pectoris undergoing percutaneous coronary intervention. Circ J 2010; 74: 1929-1935.
36. Gil-Bernabe P, Boveda-Ruiz D, D'Alessandro-Gabazza C, Toda M, Miyake Y, Mifuji-Moroka R, et al. Atherosclerosis amelioration by moderate alcohol consumption is associated with increased circulating levels of stromal cell-derived factor-1. Circ J 2011; 75: 2269-2279.
37. Brunner S, Schernthaner GH, Satler M, Elhenicky M, Hoellerl F, Schmid-Kubista KE, et al. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: First in vivo data. Invest Ophthalmol Vis Sci 2009; 50: 392-398.
38. Li Calzi S, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, Grant MB. EPCs and pathological angiogenesis: When good cells go bad. Microvasc Res 2010; 79: 207-216.
39. Pearson JD. Endothelial progenitor cells: An evolving story. Microvasc Res 2010; 79: 162-168.
40. Franca CN, Pinheiro LF, Izar MC, Brunialti MK, Salomao R, Bianco HT, et al. Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J 2012; 76: 729-736.